OBJECTIVE: Caustic substance ingestion in childhood is a public health issue in developing countries, and several management protocols have been proposed to prevent the resulting esophageal strictures. The role of corticosteroids in preventing corrosive-induced strictures is controversial. Our aim was to study the influence of high doses of corticosteroids in preventing esophageal strictures. METHODS: Eighty-three children with a mean age of 4.10 ± 2.63 years and with grade IIb esophageal burns (an esophagogastroscopy was performed within 24–48 hours of injury) due to corrosive substance ingestion were enrolled in our study between 2005 and 2008. Forty-two children (study group) received methylprednisolone (1 g/1.73 m2 per day for 3 days), ranitidine, ceftriaxone, and total parenteral nutrition. Forty-one children (control group) were administered the same regimen excluding methylprednisolone. Stricture development was compared between groups based on endoscopic and radiologic findings. RESULTS: During the endoscopic examination, stricture development was observed in 4 patients (10.8%) in the study group and in 12 patients (30%) in the control group. The difference was statistically significant (P = .038). The stricture development rate in the upper gastrointestinal system with barium meal was 14.3% and 45.0% in the study and control groups, respectively. The difference was statistically significant (P = .004). The duration of total parenteral nutrition was shorter in the study group compared with the control group (P = .001). High doses of methylprednisolone were well tolerated in the study group without any side effects. CONCLUSIONS: High doses of methylprednisolone used for the management of grade IIb esophageal burns may reduce stricture development.
1 September 2018 in İstanbul Tıp Fakültesi Dergisi
Celiac disease (CD) is an autoimmune disorder triggered by gluten ingestion, characterized by the development of specific autoantibodies. An increased inci
The aim of the study was to evaluate prevalence of functional gastrointestinal disorders (FGID) in children with asthma and to determine the relationship between FGID and asthma control and anxiety. Two hundred fifty children aged 6 to 18 years with asthma were enrolled in this single-center study. The FGID screening questionnaire, an asthma control test, and the Revised Children’s Anxiety and Depression Scale (RCADS) were applied to the patients. A significant difference was observed only in the rate of anxiety in children with FGID in the 6 to 11 age group. The incidence of FGID in girls was found to be higher than that in boys in the 12 to 18 age group ( P = .015). While a statistically significant difference was found between FGID and asthma control in cases between the ages of 12 to 18 ( P = .001), no difference was observed in the 6 to 11 age group. The prevalence of FGID is high in children with asthma, especially in adolescence.